influence association with RNA-binding proteins that alter gene expression (Figure 1C; Kedde et al., 2007) .
The reported link between the use of shorter 3′UTR isoforms, avoidance of regulation by miRNAs, and enhanced cellular proliferation is consistent with several previous observations. Global downregulation of miRNA expression is common in cancer (Lu et al., 2005) and promotes cellular transformation and tumorigenesis (Kumar et al., 2007) ; miRNAs influence many aspects of cellular proliferation and cell-cycle progression (reviewed in Carleton et al., 2007) . Moreover, many genes have been evolutionarily selected for enrichment or depletion of miRNA binding sites through changes in the lengths of their 3′UTRs, and the avoidance of miRNA target sites is correlated with spatial and temporal coexpression of mRNAs and miRNAs (Stark et al., 2005) .
The work by Sandberg et al. points to a dynamic interplay between alternative polyadenylation of mRNAs and regulation by miRNAs. The coexpression of genes with miRNAs that target them might be required in specific cell types in certain circumstances. Shifting gene expression to shorter 3′UTR isoforms, which are devoid of target sequences for the specific miRNAs, is a mechanism to avoid an undesirable decrease in protein expression ( Figure 1B) . It is also conceivable that specific RNA-binding proteins are involved in this process ( Figure 1C) . Future experiments should determine the molecular mechanisms governing this global switch in PAS usage. Cell Dev. Biol. 16, 49-58. Filipowicz, W., Bhattacharyya, S.N., and Sonenberg, N. (2008) . Nat. Rev. Genet. 9, 102-114.
Kedde, M., Strasser, M.J., Boldajipour, B., Vrielink, J.A., Slanchev, K., le Sage, C., Nagel, R., Voorhoeve, P.M., van Duijse, J., Orom, U. A., et al. (2007) Molecular networks often adapt to perform different tasks in different organisms. For example, the small GTPbinding Ras proteins that are implicated in nutrient uptake in the budding yeast Saccharomyces cerevisiae have evolved into central regulators of growth and proliferation in metazoans. In this issue of Cell, Bassermann and coworkers describe a similarly striking example of "molecular bricolage," a clever adaptation of materials at hand for a new purpose. The authors show that the conserved regulatory network consisting of the phosphatase Cdc14, the ubiquitin ligase anaphase-promoting complex or cyclosome (APC/C), and the Polo-like kinase 1 (Plk1)-long implicated in controlling mitotic exit in budding yeast-is repurposed in human cells to mediate the DNA-damage-induced G2 cell-cycle block.
The goal of cell division is to generate two daughter cells genetically identical to the mother cell. To minimize genetic instability, eukaryotes have developed surveillance mechanisms called checkpoints (Figure 1 ) consisting of highly conserved signal transduction pathways that monitor cell-cycle progression and delay the process when key events go wrong to allow for error correction. The G2 checkpoint is an important component of the DNA-damage response, which delays entry into mitosis in the presence of DNA lesions. During the G2 block, numerous proteins including the ATR kinase collaborate to activate the kinase Chk1, which maintains a cellcycle arrest through inhibition of mitotic cyclin-dependent kinase (Cdk1) activity. Chk1 inactivates the Cdc25 protein to ensure that Cdk1 remains in an inactive state ( Figure 1 ). Cell-cycle reentry following DNA repair is mediated by Plk1, whose kinase activity triggers the degradation of a series of targets, including Claspin, an adaptor protein required by cdc14B and APc/c Tackle DnA Damage Peter De Wulf 1 and Rosella Visintin 1, * ATR to maintain Chk1 activity (Branzei and Foiani, 2008; Harper and Elledge, 2007) . Although many of the proteins mediating the G2 cell-cycle block and recovery from it are known, numerous open questions remain. For example, how is Plk1 activity restrained during the G2 cell-cycle block? Bassermann and colleagues set out to elucidate this question and implicated the APC/C ubiquitin ligase complex in Plk1 degradation during the DNA-damage response in cultured human cells (Figure 1, shaded box) . The APC/C, a central regulator of the cell cycle, is a multisubunit ubiquitin ligase thought to primarily function during mitosis and in G1. Its activity depends on two distinct activator proteins named Cdc20 and Cdh1 (the resulting complexes with the APC/C are indicated as APC/C Cdc20 and APC/C Cdh1 , respectively). Whereas Cdc20 mediates entry into anaphase, Cdh1 mediates events that are important for mitotic exit and maintenance of the G1 state. APC/ C Cdh1 activity is suppressed during the G2 phase of the cell cycle. However, the APC/C Cdh1 is transiently activated in G2 upon DNA damage (Sudo et al., 2001 ). Bassermann et al. now connect this transient activation of the APC/C Cdh1 to the regulation of Plk1. Out of 15 known APC/C Cdh1 substrates, the authors found that only Plk1 was degraded while others such as Claspin appeared to be protected from degradation despite being ubiquitinated. Indeed, DNA-damaged cells expressing a mutant form of Plk1 not recognized by the APC/C Cdh1 (and thus not degraded) showed a greater tendency to escape from the DNA-damage checkpoint and enter mitosis. Intriguingly, though Cdh1 is a not an essential gene for mouse embryonic and somatic cells, mouse embryonic fibroblasts lacking Cdh1 showed increased genomic instability, a possible consequence of a faulty DNA-damage checkpoint (GarciHiguera et al., 2008) .
If APC/C Cdh1 activity is normally suppressed in G2, how is it reactivated to downregulate Plk1 protein levels upon DNA damage in human cells? Previous studies have shown that in order to interact with the APC/C, the Cdk-mediated phosphorylation of Cdh1 must be reversed. In budding yeast, this dephosphorylation is mediated by the conserved phosphatase Cdc14, a protein crucial for exit from mitosis (Stegmeier and Amon, 2004) . Cdc14 activity in budding yeast is modulated spatially: Cdc14 is kept inactive inside the nucleolus by its inhibitor Cfi1/Net1 until metaphase. During early anaphase, Cdc14 is released into the nucleus. In mid-to-late anaphase, it also moves into the cytoplasm to reach its myriad substrates, including Cdh1 (Stegmeier and Amon, 2004) . In humans, the two orthologs of Cdc14 (Cdc14A and Cdc14B) localize dynamically during the cell cycle. Cdc14A localizes to interphase centrosomes and regulates centrosome separation, whereas Cdc14B localizes to interphase nucleoli similarly to budding yeast Cdc14. During mitosis, both isoforms disperse throughout the cell (Krasinska et al., 2007) , but the details of their activity following their release remain poorly understood.
Guided by previous studies in budding yeast, Bassermann and colleagues examined if Cdc14A and Cdc14B change localization upon DNA damage. The authors found that following the activation of the DNA-damage response, only Cdc14B relocalized from the nucleolus into the nucleus. Furthermore, Cdc14B bound to Cdh1 and triggered APC/ C Cdh1 activity in a manner similar to that observed in budding yeast. Consistent with a role in regulating Plk1 levels via regulation of Cdh1, silencing Cdc14B led to a stabilization of the Plk1 protein similar to that observed when Cdh1 is silenced. Though the role of Cdc14 in mitotic exit is well established in budding yeast, clues to its function in higher eukaryotes have been scanty until now. This exciting demonstration of association between Cdc14 activity and the DNA-damage response opens the door to many new questions. For example, does an analogous G2 regulatory pathway exist in budding yeast or is this newly discovered activity of Cdc14 and its targets a reflection of nature's creative use of a conserved pathway to provide solutions for a specific need?
This regulatory network uncovered by Bassermann et al. also opens up new areas of inquiry. One question concerns the mechanism by which the APC/C Cdh1 is activated. Previous analyses have demonstrated that the APC/C Cdh1 is kept inactive during G2 not only via phosphorylation but also by its inhibitor Emi1 (Di Fiore and Pines, 2008) . But how does Emi integrate into this role of APC/C Cdh1 during the DNA-damage response? Is its inactivation required for Plk1 degradation? It will be important in future experiments to examine the fate of Emi1 during the DNA-damage response. Another question pertains to how and via what signals Cdc14B becomes released from the nucleolus upon DNA damage. In budding yeast, the release of Cdc14 occurs DNA damage during the cell cycle triggers the DNA-damage checkpoint and results in a block of the cell cycle (right) at G2 via the inhibition of mitotic cyclin-dependent kinase (Cdk1) activity. Bassermann et al. (2008) find a new regulatory pathway of the G2 DNA-damage checkpoint (shaded box) in which the phosphatase Cdc14B activates the ubiquitin ligase anaphase-promoting complex or cyclosome (APC/C Cdh1 ) to degrade the Polo-like kinase 1 (Plk1) and arrest the cell cycle. Plk1 is required for cell-cycle reentry as its kinase activity triggers inactivation (by the ubiquitin ligase SCF βTrCP ) of Cdk1 inhibitors such as Wee1 and Claspin, an adaptor protein required by the kinase ATR to maintain Chk1 inhibition of Cdc25, an activator of Cdk1. During the G2 cell-cycle arrest, APC/C Cdh1 specifically degrades only Plk1 and not other substrates such as Claspin due to the action of the deubiquitinating enzyme Usp28. Upon DNA repair, Cdk1 is reactivated to allow cell-cycle progression from G2 to mitosis. through the sequential action of two regulatory networks, the FEAR (Cdcfourteen early anaphase release) network and the MEN (mitotic exit network) (Stegmeier and Amon, 2004) . Although the components of both pathways are not fully conserved in humans, the initiation and maintenance of released Cdc14 in budding yeast depend on the Plk1 homolog Cdc5. By activating APC/C Cdh1 , which in turn promotes the degradation of Cdc5, Cdc14 triggers its own inactivation (Visintin et al., 2008) . It is possible that a similar mechanism underlies the Cdc14B-mediated DNA-damage response. If Plk1 proves to be important for the release of Cdc14B in the DNA-damage response, then the same circuitry could govern both the entry and exit from the G2 cell-cycle block as Cdc14 inactivation could then allow for the accumulation of Plk to promote cell-cycle reentry. The work by Bassermann et al. suggests broader roles for both Cdc14 and APC/ C Cdh1 in the regulation of the cell cycle, thus shedding light on an interesting new pathway in the cellular response to DNA damage.
The discovery that the transcriptional activator CLOCK functions as a histone acetyltransferase (HAT) (Doi et al., 2006) has implicated chromatin remodeling in the circadian regulation of gene expression. In this sense, the existence of a histone deacetylase (HDAC) that counteracts the HAT activity of CLOCK could perhaps have been anticipated. However, not all deacetylases achieve their goal in the same way, and this is in part why the work by Asher et al. (2008) and Nakahata et al. (2008) presented in this issue is of such compelling interest.
Both groups show that the HDAC SIRT1 is involved in regulating the amplitude of circadian clock-controlled gene expression. Mammalian SIRT proteins (homologs of Saccharomyces mating type cassette regulator Sir2p) use energy stored in nicotinamide adenine dinucleotide (NAD + ) to catalyze the removal of the acetyl group from substrates (Sauve et al., 2006) . Given that cellular NAD + levels are coupled to metabolic activity, the identification of SIRT1 as a histone deacetylase that counteracts CLOCK function brings this protein with its extensive connections, both to aging and energy metabolism, into the circadian fold.
Analysis of the molecular basis of the circadian rhythm in the fruit fly Drosophila, the fungus Neurospora, mice, and human cells in culture has revealed at its core a common architecture, a transcription-translation feedback loop in which a heterodimeric transcription factor, whose parts interact via PAS domains, drives the expression of proteins that turn down the activity of their heterodimeric activator. In mammalian cells, the transcriptional acti-
